ModiQuest Research, a leading custom antibody generation and development company, will launch a novel platform to generate high affinity antibodies specific for intractable drug targets such as low immunogenic membrane spanning proteins. This novel highly successful approach has already demonstrated that large panels of antibodies recognizing a broad variety of epitopes can be generated to … Continue reading